 It has weak antimineralocorticoid activity and no other important hormonal activity.Dydrogesterone was developed in the 1950s and introduced for medical use in 1961.It is available widely throughout Europe, including in the United Kingdom, and is also marketed in Australia and elsewhere in the world.